ArticlePloS one2019

A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib.

Hiroaki Kitamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.